Los puntos clave no están disponibles para este artículo en este momento.
To provide detailed guidance on the administration of systemic bevacizumab in patients with recurrent respiratory papillomatosis (RRP) based on a detailed review of the scientific literature and a consensus of experts with real-world clinical experience.
Best et al. (Sat,) studied this question.